STAAR Surgical Company
STAA
$18.03
$0.150.84%
NASDAQ
| 12/27/2024 | 09/27/2024 | 06/28/2024 | 03/29/2024 | 12/29/2023 | |
|---|---|---|---|---|---|
| Net Income | -194.66% | 6.99% | -35.61% | -53.32% | -46.18% |
| Total Depreciation and Amortization | 34.48% | 8.12% | 5.46% | 13.27% | 13.64% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 18.93% | 2.58% | 17.10% | 41.43% | 41.83% |
| Change in Net Operating Assets | 86.77% | 84.82% | 64.97% | 59.07% | -41.41% |
| Cash from Operations | 7.75% | 426.64% | 137.65% | 17.42% | -59.14% |
| Capital Expenditure | -28.62% | -8.53% | -46.25% | -10.93% | -0.44% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -138.71% | -85.89% | 165.46% | 180.59% | 166.92% |
| Cash from Investing | -179.65% | -431.29% | 138.74% | 156.01% | 147.54% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.48% | -1.23% | 1.23% | -6.00% | -27.78% |
| Issuance of Common Stock | -23.56% | -18.36% | 83.46% | 79.93% | 14.84% |
| Repurchase of Common Stock | 28.23% | 33.35% | 23.94% | 20.12% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -22.81% | -14.47% | 127.62% | 112.38% | -10.63% |
| Foreign Exchange rate Adjustments | -650.00% | 445.30% | -322.67% | -59.19% | 123.43% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -140.26% | 2,120.50% | 190.99% | 230.03% | 185.28% |